Nykode Therapeutics ASA
OTC:VACBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nykode Therapeutics ASA
OTC:VACBF
|
NO |
|
D
|
Duta Anggada Realty Tbk PT
IDX:DART
|
ID |
|
RHB Bank Bhd
KLSE:RHBBANK
|
MY |
|
A
|
Alefarm Brewing A/S
F:902
|
DK |
|
HF Company SA
F:HFC
|
FR |
|
Srisawad Corporation PCL
OTC:SRAWY
|
TH |
|
IFAST Corporation Ltd
F:1O3
|
SG |
|
Q
|
QTCG PCL
SET:QTCG
|
TH |
|
EcoPro BM Co Ltd
KOSDAQ:247540
|
KR |
|
X
|
Xunlei Ltd
DUS:4XN
|
CN |
|
S
|
S&K Polytec Co Ltd
KOSDAQ:091340
|
KR |
|
L
|
Lotte Rental Co Ltd
KRX:089860
|
KR |
|
Terra Balcanica Resources Corp
OTC:TEBAF
|
CA |
|
Baramulti Suksessarana Tbk PT
IDX:BSSR
|
ID |
|
P
|
Pharol SGPS SA
LSE:0FQ8
|
PT |
|
K
|
King Gen PCL
SET:KGEN
|
TH |
|
R
|
Rath AG
VSE:RAT
|
AT |
|
Accentis NV
F:D1Z
|
BE |
|
A
|
Autozone Inc
SWB:AZ5
|
US |
|
M
|
Mclaren Resources Inc
F:3ML
|
CA |
|
I
|
Immutable Holdings Inc
F:B8X0
|
CA |
|
M
|
Mida Leasing PCL
SET:ML
|
TH |
Bankruptcy Probability
Nykode Therapeutics ASA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nykode Therapeutics ASA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NO |
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
1B NOK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
500.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
234.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
94.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nykode Therapeutics ASA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nykode Therapeutics ASA has total debt of 1.3m USD. This includes both short-term (0 USD) and long-term (1.3m USD) debt.
You can find a full breakdown on its Balance Sheet.